On 2025-05-15, Taysha Gene Therapies, Inc. (TSHA) announced earnings per share of $-0.08 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.08.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.08 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-0.08 | $-0.08 |
| 2025-02-26 | 2024-12-31 | $-0.08 | $-0.07 |
| 2024-11-13 | 2024-09-30 | $-0.08 | $-0.09 |
| 2024-08-12 | 2024-06-30 | $-0.10 | $-0.09 |
| 2024-05-14 | 2024-03-31 | $-0.11 | $-0.10 |
| 2024-03-19 | 2023-12-31 | -- | $0.35 |
| 2023-11-14 | 2023-09-30 | $-0.13 | $-0.13 |
| 2023-08-14 | 2023-06-30 | $-0.31 | $-0.38 |
| 2023-05-11 | 2023-03-31 | $-0.39 | $-0.28 |
| 2023-03-28 | 2022-12-31 | $-0.41 | $-0.99 |
| 2022-11-08 | 2022-09-30 | $-0.89 | $-0.64 |
| 2022-08-11 | 2022-06-30 | $-1.05 | $-0.84 |
| 2022-05-16 | 2022-03-31 | $-1.04 | $-1.31 |
| 2022-03-31 | 2021-12-31 | $-1.21 | $-1.32 |
| 2021-11-10 | 2021-09-30 | $-1.02 | $-1.35 |
| 2021-08-16 | 2021-06-30 | $-0.81 | $-1.09 |
| 2021-05-11 | 2021-03-31 | $-0.54 | $-0.87 |
| 2020-11-12 | 2020-09-30 | $0.07 | $-1.28 |